The DNA FACE™ concept has been successfully used to develop prototype pro-regenerative drug. The EP 3.549.947.B1 patent is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk, Gdańsk Medical University and Gdańsk Technical University financed by R&D grant from The National Centre for Research and Development STRATEGMED1/235077/9/NCBR/2014 (2014-2017): “Novel technologies for pharmacological stimulation of regeneration.”
One of the leading current trends in technology is the miniaturization of devices to the microscale and nanoscale. The highly advanced approaches are based on biological systems, subjected to bioengineering using chemical, enzymatic and recombinant methods. We have utilized the biological affinity towards cellulose of the cellulose binding domain (CBD) fused with recombinant proteins for the generation of functionalized microparticles, approaching nanoscale. This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk, Gdańsk Medical University and Gdańsk Technical University financed by R&D grant from The National Centre for Research and Development TECHMATSTRATEG2/410747/11/NCBR/2019 (2019-2022): „New generation bioactive molecules delivery systems, based on chemically synthesized and obtained through genetic engineering” is dedicated to the construction of several classes of novel bionanoparticles fused with concatemeric proteins, based on DNA-FACE™.
Bacteriophages associated with thermophiles are gaining increased attention due to their pivotal roles in various biogeochemical and ecological processes, as well as their applications in biotechnology and bionanotechnology. Although thermophages are not suitable for controlling bacterial infections in humans or animals, their individual components, such as enzymes and capsid proteins, can be employed in molecular biology and significantly contribute to the enhancement of human and animal health. This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk, Gdańsk Medical University and Gdańsk Technical University financed by R&D grant from The National Centre for Research and Development TECHMATSTRATEG2/410747/11/NCBR/2019 (2019-2022): „New generation bioactive molecules delivery systems, based on chemically synthesized and obtained through genetic engineering” is dedicated to the construction of several classes of novel bionanoparticles fused with concatemeric proteins, based on DNA-FACE™.